Skip to main content
CTTH logo

CTTH · Ctt Pharmaceutical Holdings, Inc.

Track CTTH — free
$0.05 +0.00 (+2.25%) At close · Sep 3
Market Cap
$1.07M
Shares
21.35M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Net Income
-$672.16K -3454.3%
FY2014 Net Income FY2010–FY2014
Diluted EPS
$0.01 +109.1%
FY2013 Diluted EPS FY2010–FY2013
Operating Cash Flow
-$72.25K -34469.4%
FY2014 Operating Cash Flow FY2010–FY2014

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2014 FY2013 FY2012 FY2011 FY2010
$57.15K $17.64K $3844 $158.35K $316.41K $309.47K
$0 $70.37K
$1.67M $672.16K $18.91K $1.19M $757.94K $2.07M
-$672.16K -$18.91K -$1.19M -$757.94K -$2.07M
$0 -$1.52M $0
-$1.67M -$672.16K -$18.91K -$1M $3.74M -$1.1M
$0 -$495.45K
-$1.66M -$669.06K -$17.5K -$892.22K $3.74M
USD/shares $0.05 $0.01 -$0.11 $0.42 -$0.13
USD/shares $0.03 $0.01 -$0.11 $0.40 -$0.13
shares 16.34M 9.41M 9.41M 8.92M 8.47M
shares 16.34M 9.41M 9.41M 9.49M 8.47M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Coverage backlog: 1 eligible filing and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Key facts CIK 1035422 CUSIP 12651E106 Visit website